[Pre-Aug 2018] IMSCAR
- Paper › Research › Not peer-reviewed
- Published
Abacavir hypersensitivity: Is pre-prescription genotyping cost-effective?
Hughes, D., Hughes, D. A. & Pirmohamed, M., 1 Sept 2003.Research output: Contribution to conference › Paper
- Published
Abacavir hypersensitivity: Is pre-prescription genotyping cost-effective?
Hughes, D., Hughes, D. A. & Pirmohamed, M., 1 Nov 2003.Research output: Contribution to conference › Paper
- Published
Abacavir hypersensitivity: Is pre-prescription genotyping cost-effective?
Hughes, D. & Hughes, D. A., 1 Jun 2003.Research output: Contribution to conference › Paper
- Published
Abacavir hypersensitivity: Is pre-prescription genotyping cost-effective?
Hughes, D. & Hughes, D. A., 1 May 2003.Research output: Contribution to conference › Paper
- Published
Accurate and practical dosing of African populations using a height, weight and age model designed for lapdap
Hughes, D., Hughes, D. A. & Bagust, A., 1 Nov 2002.Research output: Contribution to conference › Paper
- Published
Adherence with HAART: pharmacoeconomic considerations
Hughes, D. & Hughes, D. A., 1 Jun 2007.Research output: Contribution to conference › Paper
- Published
Adverse drug reactions in economic evaluations
Hughes, D. & Hughes, D. A., 1 Jul 2007.Research output: Contribution to conference › Paper
- Published
Adverse drug reactions in economic evaluations
Hughes, D. & Hughes, D. A., 1 Mar 2007.Research output: Contribution to conference › Paper
- Published
Adverse drug reactions: analysis by regulatory authorities and by economists
Hughes, D. & Hughes, D. A., 1 Apr 2007.Research output: Contribution to conference › Paper
- Published
An economic evaluation of the Incredible Years Child Parenting Programme.
Kelleher, A., Edwards, R. T., Bywater, T. & Hutchings, J., 6 Jul 2006.Research output: Contribution to conference › Paper